Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 3/20 | 1.00 |
| ▸ | NSD2 | O96028 | 3/20 | 1.00 |
| ▸ | PAX8 | Q06710 | 3/20 | 1.00 |
| ▸ | ABL1 | P00519 | 1/20 | 1.00 |
| ▸ | PLCG1 | P19174 | 1/20 | 1.00 |
| ▸ | CES1 | P23141 | 1/20 | 1.00 |
| ▸ | RIN1 | Q13671 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 0.90 |
| ▸ | PTPRC | P08575 | 2/20 | 0.78 |
| ▸ | CTSL | P07711 | 1/20 | 0.78 |
| ▸ | CTSS | P25774 | 1/20 | 0.78 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.73 |
| ▸ | THRB | P10828 | 1/20 | 0.73 |
| ▸ | BLM | P54132 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | S100A4 | P26447 | 6/20 | 0.65 |
| ▸ | CDC25B | P30305 | 3/20 | 0.65 |
| ▸ | PADI1 | Q9ULC6 | 3/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29419580 | 1.00 | TDP2 (1.00) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL4236482 | 0.97 | TDP2 (0.95) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL3275080 | 0.97 | TDP2 (0.95) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL27145668 | 0.97 | TDP2 (0.95) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL5696693 | 0.97 | TDP2 (0.95) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL579998 | 0.95 | GAA (1.00) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL30774319 | 0.95 | GAA (1.00) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL29551149 | 0.95 | GAA (1.00) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL5915065 | 0.90 | TDP2 (0.81) | TDP2NSD2PAX8ABL1PLCG1 | |
| SCHEMBL30385090 | 0.89 | TDP2 (0.79) | TDP2NSD2PAX8ABL1PLCG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1394 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629667-B2 | Di-nitrogen ligands for supported coordinated platinum hydrosilylation catalysts | THE TRUSTEES OF INDIANA UNIVERSITY (US) | 2026-05-19 | — | — | US | claimed |
| US-12628491-B2 | Organic-inorganic adhesion layer and its use in perovskite solar cells and modules | Tandem PV (US) | 2026-05-12 | — | — | US | claimed |
| US-20250374922-A1 | METHOD FOR PREPARING ANTIBACTERIAL PBAT FOAMED MATERIAL | FUJIAN KAIJI POLYMER MAT CO LTD (CN) | 2025-12-11 | — | — | US | claimed |
| WO-2025043152-A1 | METHODS OF DEALKENYLATIVE AMINATION AND AZIDATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-02-27 | — | — | WO | claimed |
| US-20240413352-A1 | ENZYME ELECTRODE HAVING AN INTEGRATED RESERVOIR | UNIVERSITE GRENOBLE ALPES (FR) | 2024-12-12 | — | — | US | claimed |
| US-20240398294-A1 | Disposable electrochemical biosensor based on NAD(P)-dependent dehydrogenase and diaphorase | GLAS TRUST COMPANY LLC | 2024-12-05 | — | — | US | claimed |
| US-20240334824-A1 | Receptor material, synthesis method and use thereof | SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-10-03 | — | — | US | claimed |
| EP-4416776-A2 | ENZYME ELECTRODE HAVING AN INTEGRATED RESERVOIR | Centre National de la Recherche Scientifique (FR) | 2024-08-21 | — | — | EP | claimed |
| US-12064243-B2 | Disposable electrochemical biosensor based on NAD(P)-dependent dehydrogenase and diaphorase | NOVA BIOMEDICAL CORPORATION (US) | 2024-08-20 | — | — | US | claimed |
| CN-118344406-A | Lysosome-targeted ruthenium complex and preparation and application thereof | 温州医科大学慈溪生物医药研究院 | 2024-07-16 | — | — | CN | claimed |
| WO-2004051774-A2 | ENZYME IMMOBILIZATION FOR USE IN BIOFUEL CELLS AND SENSORS | ST. LOUIS UNIVERSITY (US) | 2004-06-17 | — | — | WO | claimed |
| US-20040101741-A1 | Enzyme immobilization for use in biofuel cells and sensors | ST. LOUIS UNIVERSITY | 2004-05-27 | — | — | US | claimed |
| WO-2004038401-A2 | BIOSENSOR HAVING HEMATOCRIT AND OXYGEN BIASES | ABBOTT LABORATORIES (US) | 2004-05-06 | — | — | WO | claimed |
| US-20040079653-A1 | Biosensor having improved hematocrit and oxygen biases | ABBOTT DIABETES CARE INC. | 2004-04-29 | — | — | US | claimed |
| US-6720420-B2 | AROMATIC, HETEROAROMATIC, OR ALIPHATIC SUBSTITUENTS AT THE 2 POSITION OF THE OXAZINE MOIETY; REACTING 3,3-DISUBSTITUTED ACRYLIC ACID, AZIDE SOURCE, QUINONE WITH CATALYTIC TRIPHENYLARSENIC OXIDE AND DBU; QUICKLY FADING GRAY COLOR | JOHNSON & JOHNSON VISION CARE, INC. | 2004-04-13 | — | — | US | claimed |
| WO-2003057679-A9 | PHOTOCHROMIC OXAZINE COMPOUNDS AND METHODS FOR THEIR MANUFACTURE | JOHNSON & JOHNSON VISION CARE (US) | 2004-02-26 | — | — | WO | claimed |
| US-20030149032-A1 | Photochromic oxazine compounds and methods for their manufacture | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2003-08-07 | — | — | US | claimed |
| WO-2003057679-A1 | PHOTOCHROMIC OXAZINE COMPOUNDS AND METHODS FOR THEIR MANUFACTURE | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2003-07-17 | — | — | WO | claimed |
| WO-2003042195-A2 | PHOTOCHROMIC OXAZINE COMPOUNDS AND METHODS FOR THEIR MANUFACTURE | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2003-05-22 | — | — | WO | claimed |
| WO-2002102861-A2 | PROCESS FOR THE (CO)POLYMERIZATION OF CONJUGATED DIENES | ENI S.P.A. (IT) | 2002-12-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149032-A1 | Photochromic oxazine compounds and methods for their manufacture | PPOX, TYR, DHPS | TDP2 978/4885NSD2 1793/4885PAX8 733/4885 |
| US-12629667-B2 | Di-nitrogen ligands for supported coordinated platinum hydrosilylation catalysts | SCO2, HAO2, PDCD1LG2 | TDP2 4049/4885NSD2 1516/4885PAX8 2209/4885 |
| US-20240334824-A1 | Receptor material, synthesis method and use thereof | TRPV4, TRPC6, RTN4 | TDP2 4376/4885NSD2 3985/4885PAX8 1839/4885 |
| US-12628491-B2 | Organic-inorganic adhesion layer and its use in perovskite solar cells and modules | EPCAM, CDH1, L1CAM | TDP2 2532/4885NSD2 802/4885PAX8 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.